MGX metagenomi.co: יחס שווי חברה להכנסות

The success of Metagenomi, Inc. (MGX) is based on the discovery of new therapeutic proteins and patents in the field of genome editing. This EV/Revenue chart visualizes this trend, where -5959.10 expresses the current value of the metric. High authority in AI-driven DNA analysis combines with a laboratory testing outsourcing model via external partners (CRO/CMO), which critically impacts the company's operational processes.
Metagenomi Inc. - פילוחים אנליטיים ומדדי מפתח (MGX)

For Metagenomi, Inc. (MGX), which utilizes external CDMO partners to scale therapeutic candidates, analyzing the current enterprise value-to-revenue ratio allows for an assessment of capitalization efficiency without distortions from debt load. This metric aggregates the market value of equity and net debt, dividing the result by sales volume, which helps investors identify consolidation zones and avoid value traps while searching for a bottom through the price action on this chart.